科拓生物：张列兵拟减持不超1.8976%股份

Core Viewpoint - The company Keta Bio announced that a specific shareholder, Zhang Liebing, plans to reduce his holdings by up to 5 million shares within the next three months, representing 1.8976% of the company's total share capital [1] Summary by Relevant Sections - Shareholder Reduction Plan - Zhang Liebing currently holds 11,004,613 shares, which is 4.1764% of the total share capital [1] - The reduction will occur through centralized bidding and block trading from October 16, 2025, to January 15, 2026 [1] - The reason for the reduction is personal funding needs [1] - Compliance with Lock-up and Reduction Commitments - Zhang Liebing has fulfilled all commitments regarding share lock-up and reduction made during the company's initial public offering [1] - Investor Advisory - The company advises investors to pay attention to the implementation progress of the reduction plan and associated market risks [1]